Alphatec Spine Inc.
Carlsbad, California, 92008, United States
Location status: Recruiting
NCT Number: NCT05648474
This study is designed to evaluate the clinical utility of a known intraoperative neuromonitoring modality (SSEP) using saphenous nerve as the site of stimulation to identify changes to the lumbar nerves which may be at risk during the lateral lumbar interbody fusion (LLIF) procedure.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Carlsbad, California, 92008, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No study specific intervention is performed. Intraoperative neuromonitoring system that is observed in this study is for assessing the health of the lumbar plexus during lateral lumbar interbody fusion surgery
Time frame: 6 weeks or until new or worsened neural deficits are resolved, but not exceeding 12 months.
This outcome measure determines the utility of the saphenous nerve SSEP monitoring based on the correlation of intraoperative neuromonitoring results with new or worsened postoperative neural deficits, as measured by motor and sensory physical exam.
Time frame: 6 weeks or until new or worsened neural deficits are resolved, but not exceeding 12 months.
This outcome measure includes:
Alphatec Spine, Inc.
Industry
Advanced Techniques in Intraoperative Monitoring for the Lateral Lumbar Interbody Fusion Procedure: a Utility Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02023372
Bone Diseases, Intervertebral Disc Degeneration
Charlotte, North Carolina, United States
View Trial DetailsNCT04594980
Bone Diseases, Intervertebral Disc Degeneration
Moscow, Russia
View Trial DetailsNCT05110833
Bone Diseases, Bone Diseases, Infectious
Minneapolis, Minnesota, United States
View Trial DetailsNCT02617563
Bone Diseases, Intervertebral Disc Degeneration
Buenos Aires, Argentina
View Trial Details